{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:17Z","timestamp":1790175077968,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.humimm.2005.01.031","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T12:45:44Z","timestamp":1109681144000},"page":"422-430","source":"Crossref","is-referenced-by-count":36,"title":["Use of Intravenous Immunoglobulin in Patients With Acquired von Willebrand Syndrome"],"prefix":"10.1016","volume":"66","author":[{"given":"Augusto B.","family":"Federici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2005.01.031_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand\u2019s syndrome in systemic lupus erythematosus","volume":"31","author":"Simone","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib2","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0889-8588(18)30283-1","article-title":"Acquired von Willebrand\u2019s disease","volume":"6","author":"Jakway","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.humimm.2005.01.031_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10428199609074364","article-title":"Acquired von Willebrand disease in myeloproliferative disorders","volume":"22","author":"van Genderen","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humimm.2005.01.031_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<139::AID-AJH7>3.0.CO;2-Y","article-title":"Acquired von Willebrand\u2019s disease","volume":"54","author":"Rinder","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","article-title":"Acquired von Willebrand disease","volume":"103","author":"Tefferi","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","article-title":"Acquired von Willebrand syndrome\u2014report of 10 cases and review of the literature","volume":"5","author":"Nitu-Whalley","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.humimm.2005.01.031_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1517\/13543784.9.2.347","article-title":"Therapeutic approaches to acquired von Willebrand syndrome","volume":"9","author":"Federici","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.humimm.2005.01.031_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0037-1613993","article-title":"Acquired von Willebrand syndrome","volume":"84","author":"Veyradier","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/sj.thj.6200137","article-title":"Acquired von Willebrand syndrome","volume":"2","author":"Federici","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.humimm.2005.01.031_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/beha.2001.0141","article-title":"Acquired von Willebrand syndromes","volume":"14","author":"Michiels","year":"2001","journal-title":"Best Pract Res Clin Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2002-27824","article-title":"Acquired von Willebrand syndrome","volume":"28","author":"Budde","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0037-1619606","article-title":"Acquired von Willebrand syndrome 2004","volume":"24","author":"Federici","year":"2004","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.humimm.2005.01.031_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","article-title":"Studies of the pathophysiology of acquired von Willebrand disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies","volume":"64","author":"Mannucci","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1615235","article-title":"Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome","volume":"80","author":"van Genderen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib16","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2516.2003.00750.x","article-title":"A new ELISA assay for diagnosis of acquired von Willebrand syndrome","volume":"9","author":"Siaka","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.humimm.2005.01.031_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(79)80293-0","article-title":"Acquired von Willebrand disease in a patient with Wilms tumor","volume":"95","author":"Noronha","year":"1979","journal-title":"J Pediatr"},{"key":"10.1016\/j.humimm.2005.01.031_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V58.4.665.665","article-title":"Acquired von Willebrand\u2019s disease in association with Wilm\u2019s tumor","volume":"58","author":"Scott","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1661144","article-title":"Acquired von Willebrand\u2019s syndrome associated with hydatid disease of the spleen\u2014disappearance after splenectomy","volume":"52","author":"Richard","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.7326\/0003-4819-105-1-54","article-title":"Cessation of recurrent bleeding from gastrointestinal angiodysplasia after aortic valve replacement","volume":"105","author":"Cappell","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V71.6.1648.1648","article-title":"Changes in von Willebrand factor during cardiac surgery","volume":"71","author":"Weinstein","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.1992.10.3.422","article-title":"Acquired von Willebrand disease in Wilms\u2019 tumor patients","volume":"10","author":"Coppes","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humimm.2005.01.031_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1992.tb04562.x","article-title":"Acquired type II von Willebrand\u2019s disease associated with adrenal cortical carcinoma","volume":"80","author":"Facon","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(96)91240-4","article-title":"Reversal of aortic stenosis, bleeding gastrointestinal angiodysplasia, and von Willebrand syndrome by aortic valve replacement","volume":"347","author":"Anderson","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2005.01.031_bib26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/01.CIR.102.11.1290","article-title":"Proteolysis of von Willebrand factor and shear-stress-induced platelet aggregation in patients with aortic valve stenosis","volume":"102","author":"Pareti","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.humimm.2005.01.031_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1981.tb02700.x","article-title":"Acquired von Willebrand\u2019s disease caused by a chronic granulocytic leukemia","volume":"48","author":"Duran-Saurez","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.1985.tb02830.x","article-title":"Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma","volume":"61","author":"Tran","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000204725","article-title":"Acquired von Willebrand\u2019s disease in association with essential thrombocythemia","volume":"87","author":"Murakawa","year":"1992","journal-title":"Acta Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2007-996119","article-title":"Acquired von Willebrand disease in patients with high platelet counts","volume":"23","author":"Budde","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM197805042981802","article-title":"Acquired von Willebrand\u2019s disease","volume":"298","author":"Joist","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2257.1992.tb00367.x","article-title":"Hydroxy-ethyl starch induced acquired von Willebrand\u2019s disease","volume":"14","author":"Dalrymphyle-Hay","year":"1992","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/0140-6736(90)91235-3","article-title":"Induction of von Willebrand disease type I by valproic acid","volume":"335","author":"Kreuz","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2005.01.031_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.2830410218","article-title":"Acquired von Willebrand\u2019s disease, IgE polyclonal gammopathy and griseofulvin therapy","volume":"41","author":"Conrad","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.2830490114","article-title":"Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin","volume":"49","author":"Castaman","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-1987.x","article-title":"Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor","volume":"96","author":"Inbal","year":"1997","journal-title":"Br J Haemat"},{"key":"10.1016\/j.humimm.2005.01.031_bib38","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.1060","article-title":"Successful treatment with recombinant factor VIIa of therapy-rersistant severe bleeding in a patient with acquired von Willebrand disease","volume":"66","author":"Friederich","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib40","first-page":"143","article-title":"The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome","volume":"112","author":"Macik","year":"1988","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1988.tb02502.x","article-title":"High-dose intravenous gammaglobulin for acquired von Willebrand\u2019s disease","volume":"70","author":"Delannoy","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830410212","article-title":"Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate","volume":"41","author":"Castaman","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.2830400214","article-title":"Acquired von Willebrand disease","volume":"40","author":"Delmer","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib44","article-title":"Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin","author":"Arkel","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajh.2830460216","article-title":"Acquired von Willebrand\u2019s syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin","volume":"46","author":"Hanley","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humimm.2005.01.031_bib46","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0038-1653887","article-title":"High-dose intravenous immunoglobin delays clearance of von Willebrand factor in acquired von Willebrand disease","volume":"73","author":"Van Genderen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.humimm.2005.01.031_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00008480-199702000-00009","article-title":"Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children","volume":"9","author":"Imbach","year":"1997","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.humimm.2005.01.031_bib48","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous imune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humimm.2005.01.031_bib49","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.1974.tb06676.x","article-title":"Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity","volume":"28","author":"Meyer","year":"1974","journal-title":"Br J Haemat"},{"key":"10.1016\/j.humimm.2005.01.031_bib50","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V67.3.758.758","article-title":"Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects","volume":"67","author":"Gill","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2005.01.031_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-97-5-713","article-title":"Factor VIII activity and thyroid function","volume":"97","author":"Rogers","year":"1982","journal-title":"Ann Intern Med"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885905000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885905000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T02:12:50Z","timestamp":1586139170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885905000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0198885905000443"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2005.01.031","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}